OCP CONNECT helps laboratories ensure the success of their pharmacy strategies
Strategy – Consulting – Action
A unique approach to help you achieve your objectives.
Discover our events, our forthcoming meetings, our latest innovations.
Sharing our experience and our expertise to help you determine your strategic orientations.
The OCP CONNECT team is always available to find answers to your challenges
Stimulating sales, new brand implementation, point of sales presence and visibility for your products …
Targeting, telesales, Com’en sac...OCP CONNECT provides you with the most appropriate solution.
Mobilise a complementary target, back up the launch of an OTC product, help with advising lumbago sufferers...,…
3 Chênes
AIM
Abbott Diabetes Care
Argiletz
Asepta
BD
Boehringer Ingelheim
Bouchara Recordati
Ciba Vision
…
The OCP CONNECT team is always available to find answers to your challenges
Product risk management plans, compliance, home-based management of side effects, therapeutic education…
The pharmacist is a frontline actor in patient support.
Targeting, e-detailing, “Spot Santé”…OCP CONNECT creates and implements innovative solutions
Support pharmacies in the delivery of an anti-cancer drug, promoting appropriate useof a new treatment…
Abbott
Amgen
Aguettant
...
The OCP CONNECT team is always available to find answers to your challenges
Making stock on a new generic available on Day One, launch of a biosimilar, maintaining market share…
Targeting, distance sales, public display,.. OCP CONNECT: your partner with the most appropriate solution,
Ensuring delivery in the 24 hours following Day One, creating synergies between GPs and pharmacists ones actions
Actavis
Biogaran
Insights Agents
Mylan
Ratiopharm
Sandoz
Teva
The OCP CONNECT team is always available to find answers to your challenges
Pharmaceutical companies’ marketing approaches are changing, and communication strategies no longer target products or prescribing doctors alone. Pathology management now requires the implication of the full range of healthcare actors: patients, pharmacists, health authorities, patients’ associations, hospital staff etc.
The pharmacist is a front-line healthcare actor with respect to the patient. The pharmacist is a separate target who should be recognised in the marketing strategies adopted by the laboratories.
The pharmacist’s legitimacy is founded on multiple criteria:
The pharmacist’s role – which is already structured by the pharmacists’ ethical code – has been integrated under the HPST (Hospital, Patients, Health and Territories) law since July 2009 as a frontline healthcare actor (1).
Beyond pharmacists’ prime role in dispensation, their role in therapeutic education and patient support is now fully recognised (2).
The pharmacist is thus seen as a central actor in the battle against non-compliance.
The opportunities given by the HPST law and the developments in managing chronic illness and severe pathologies (outpatient treatment, growth of hospital-prescribed treatments…) generate new roles for pharmacists, who are entirely ready to assume them. Thus, in the next few years the pharmacy will become a key location for screening and prevention.
97% of pharmacists surveyed in the Direct Research study of May 2009 (3) are ready to participate in programmes of prevention and screening and 94% are ready to participate in therapeutic education programmes.
Furthermore, according to a BVA survey realised in April 2009 (4), 67% of pharmacists consider that they play an indispensable role in compliance and the appropriate use of treatments.
Numerous reports and studies agree that the pharmacist is not only considered as an essential healthcare actor, but is also the object of clearly-expressed patient expectations concerning the way their illnesses are handled.
The pharmacy is likewise seen as a space dedicated to the safe, effective use of healthcare products to which the patient is happy to return.
According to the BVA survey of April 2009 (4), the vast majority of patients are satisfied with the pharmacist’s handling of their problems. The survey also shows that 87% of patients are loyal to their pharmacist.
(1) Article L.5125-1-1-A of the HPST law, July 2009
(2) Actions defined under the articles L. 1161-1 to L. 1161-5
(3) Direct Research survey: “Ethical pharmaceutical companies: new promotional policies towards retail pharmacists - perspectives for 2010”. Telephone survey conducted on a population of 300 retail pharmacists – Source : Direct Research, May 2009.
(4) BVA study “Pharmacy-based accompaniment and management of patients with major illnesses”.
Your opinion interests us
